Sanjiv Rana talks with Certis Biologicals’ president and CEO, Amy O’Shea, to discuss the company’s plans following its rebranding from Certis USA to Certis Biologicals. SR: What has been the impact of the rebranding as Certis Biologicals? What has been the change in strategic priorities? Has the rebranding made Certis Biologicals a pure play biologicals company? Amy O’Shea (AOS): As we celebrated 20 years as Certis under the ownership of Mitsui & Co, we made the decision to transition our brand from Certis USA to reflect our focus in bringing biological innovations to the global market. We have a worldwide manufacturing footprint and provide biological crop protection solutions to more than 55 countries.
展开▼
